ELI-002 2P vaccine targets KRAS mutation, showing reduced relapse risk and improved survival in pancreatic and colorectal cancer patients. Two-thirds of study participants exhibited a strong immune ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback